The lowest price for Wegovy is $25/fill ⚠️ requires insurance coverage
With coverage, the savings offer can bring the cost to as little as $25/fill, when your copay before the offer is $125 or less (it saves up to $100 per 1-month fill). Denied? You can appeal, and 65%+ succeed.
Checking if you're covered?
Use the insurer directory below to see how your plan handles Wegovy.
Jump to insurer directory ↓Then find your fastest path to approval →Denied Wegovy coverage?
65%+ of appeals succeed with proper documentation.[3] Don't give up.
Get help with your appeal →✓ Free case review · ✓ Could save thousands/yearThis page shows how Wegovy coverage works across major insurers, what prior authorization typically requires, and what changes are coming in 2026. Compare coverage across BCBS, UnitedHealthcare, Aetna, Cigna, Medicare, Medicaid, TRICARE, and more.
COVERAGE OVERVIEW
The Short Answer
Short answer: Yes—but coverage varies by plan. Large employer plans are most likely to cover Wegovy with prior authorization. Most marketplace plans exclude it for weight loss. By law, basic Medicare Part D coverage excludes it for weight loss, but Medicare enrollees may qualify through the Medicare GLP-1 Bridge (outside Part D), with conditions.
- ✓ Most large employer plans may cover Wegovy with prior authorization
- ✗ Most ACA marketplace plans exclude it for weight loss; Medicare covers it for weight loss only through the Medicare GLP-1 Bridge ($50 per monthly fill, with conditions)
- ✓ Coverage may still be possible through appeals or the CV risk reduction indication
Best for: Employer plans, ACA marketplace, Medicare, Medicaid, TRICARE.
Key Coverage Facts
- Coverage varies significantly by plan—even within the same insurer, different employer plans have different formularies
- Coverage varies by employer size: 16% of mid-size employers (200-999 workers), 30% of large employers (1,000-4,999), and 43% of very large employers (5,000+) cover GLP-1 medications for weight loss[1]
- More than 88% of patients with coverage face prior authorization or other restrictions—your doctor must get approval before you can fill it
- Basic Medicare Part D coverage excludes weight-loss drugs by federal statute (Wegovy may be covered for CV risk reduction, subject to the plan’s formulary, prior authorization and exceptions process); the Medicare GLP-1 Bridge covers Wegovy for weight loss for $50 per monthly fill (July 1, 2026 – December 31, 2027), with conditions
- State Medicaid programs covering GLP-1s for obesity: 13 states (as of January 2026), though policies are evolving[2]
Coverage by Plan Type
| Plan Type | Coverage | Key Notes |
|---|---|---|
| Very large employer (5,000+) | Most likely | 43% cover; PA required |
| Large employer (1,000-4,999) | Moderate | 30% cover GLP-1s for weight loss |
| Mid-size employer (200-999) | Less likely | 16% cover GLP-1s for weight loss |
| ACA Marketplace | Rare | <1% cover obesity drugs |
| Medicare Part D | Bridge | Basic Part D coverage excludes weight loss by law; Bridge (outside Part D): $50 per monthly fill (with conditions) |
| Medicaid | Varies by state | 13 states (as of January 2026); policies evolving |
Already denied? If your insurance denied Wegovy, you still have options. Learn what to do after a Wegovy denial →
If Denied, Appeals Often Succeed
Over 65% of prior authorization appeals succeed when patients appeal—yet fewer than 12% ever file an appeal.[3] If your Wegovy coverage is denied, don't give up. See what to do after a denial →
Looking for Step-by-Step Help?
This page shows which insurers cover Wegovy. For guidance on how to navigate PA, appeals, and get approved, see our How to Get Wegovy Covered Guide.
Bottom line: Don't assume your plan covers or excludes Wegovy. Call your insurer to verify, and if denied, remember that appeals often succeed. Next step: Look up how your insurer handles coverage below.
Insurer Directory
Find Your Insurance Company
Select your insurer below to see coverage policies, prior authorization requirements, and tips for getting approved.
Coverage Changes Frequently
Insurance formularies update regularly. Always verify current coverage with your plan or check the linked pages for the latest specifics.
UnitedHealthcare / OptumRx
Plan-DependentEmployer and individual plans vary. When covered, typically requires PA + lifestyle documentation. Some OptumRx formularies have excluded Wegovy.
View UHC Coverage →Blue Cross Blue Shield
Varies by StateCoverage varies significantly by state and plan. Most require PA with BMI ≥30 or ≥27 + comorbidity and 6-12 months lifestyle documentation.
View BCBS Coverage →Cigna / Express Scripts
PA RequiredPrior authorization required with state variations. Check if Wegovy is preferred or non-preferred on your specific formulary.
View Cigna Coverage →Aetna
PA RequiredPrior authorization required. Updated 2025 policies require BMI documentation, lifestyle modification, and may have step therapy requirements.
View Aetna Coverage →CVS Caremark
Formulary VariesPBM for many employer plans. Wegovy coverage varies by employer formulary. Some formularies have excluded it entirely.
View CVS Caremark Coverage →Express Scripts
Plan-DependentCigna's PBM. Coverage depends on employer formulary. Evernorth’s optional cost cap: $200/month cap (only if your employer adds it).
View Express Scripts Coverage →OptumRx
CV vs Weight LossUnitedHealth's PBM. Many formularies cover Wegovy for CV risk reduction only, not weight loss. PA required.
View OptumRx Coverage →Anthem Blue Cross
Varies by PlanCoverage varies by state and plan type. Many commercial plans exclude GLP-1s for weight loss; some employer plans cover with PA.
View Anthem Coverage →Kaiser Permanente
Very LimitedMost standard Kaiser plans do NOT cover Wegovy for weight loss. Coverage typically requires employer opt-in. Eligibility criteria vary by region.
View Kaiser Coverage →Humana
ExcludedHumana no longer sells employer-group commercial medical plans (exit completed in 2025). Humana Medicare members may qualify through the Medicare GLP-1 Bridge. Medicaid varies by state.
View Humana Coverage →ACA Marketplace Plans
State-DependentCoverage varies by plan and state. ACA plans follow state mandates and insurer policies. Many require PA; some exclude weight loss drugs.
View Marketplace Coverage →Medicare Part D
BridgeBy federal law, basic Part D coverage excludes weight-loss medications, but the Medicare GLP-1 Bridge (outside Part D) covers Wegovy for weight loss for $50 per monthly fill (July 1, 2026 – December 31, 2027), with conditions. Wegovy may also be covered under Part D for the CV risk reduction indication, subject to the plan’s formulary, prior authorization and exceptions process.
View Medicare Details →Medicaid
13 states (as of January 2026)Coverage varies by state. 13 states (as of January 2026) covered GLP-1s for obesity. Policies change frequently—verify with your state program.
View Medicaid Coverage →TRICARE
Plan-DependentPrime & Select may cover with PA + step therapy. Coverage varies by plan type. Active duty typically pays $0 copay when covered.
View TRICARE Coverage →If your plan shows "Excluded" or "Removed," you may still have options.
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get startedOther Plans
What if My Insurer Isn't Listed?
If your insurance company isn't listed above, here's what to do:
Check Your Formulary
Look up "Wegovy" or "semaglutide" on your plan's formulary (drug list). This tells you if it's covered and at what tier.
Call Your PBM
Your pharmacy benefit manager—the company that manages drug coverage for your insurer (phone number is on your prescription card)—can confirm coverage, PA requirements, and step therapy rules.
Review Your SPD
Your Summary Plan Description (the legal document explaining your benefits) lists all exclusions. Search for "obesity," "weight loss," or "anti-obesity medications."
Self-Funded Employer Plans
If your employer self-funds their health plan (pays claims directly instead of through an insurer), they have full discretion over coverage. Your plan may cover Wegovy even if the insurer's standard plans don't—or vice versa. Contact HR or your benefits administrator.
Related Guides
Explore Other Wegovy Coverage Resources
Need more than just insurer-specific info? These guides cover the full coverage landscape.
COVERAGE OUTLOOK
What's Changing in 2026
2026: Expanding Access
The insurance landscape for Wegovy is evolving with Medicare coverage expanding and the new oral form now available. Here's what to watch.
Last updated October 6, 2026 · Key facts verified October 5, 2026
Government Programs: What's Changing
Medicare Coverage Expanding
Medicare and weight-loss GLP-1s: the Medicare GLP-1 Bridge
Through the Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027), a temporary CMS demonstration that runs outside the Part D benefit, people with eligible Part D coverage can get Wegovy, Foundayo or the Zepbound KwikPen for weight loss for $50 a month, if they meet CMS’s eligibility criteria and their prescriber gets prior authorization.
Source: CMS, Medicare GLP-1 Bridge · Facts in this box verified October 5, 2026
- BALANCE Model (Part D): Delayed, with no new start date
- Also: Wegovy may be covered under Part D for its CV risk reduction indication, subject to the plan’s formulary, prior authorization and exceptions process
Medicaid Coverage: State-by-State
State Medicaid programs covering GLP-1s for obesity: 13 states (as of January 2026), with policies evolving. Drug pricing for Medicaid is subject to confidential rebates and state negotiations.[2]
Verify coverage directly with your state Medicaid program, as policies change frequently.
Commercial Insurance: What to Watch
Oral Wegovy (January 2026)
The FDA approved oral Wegovy on December 22, 2025, and it reached pharmacies on January 5, 2026:
- Pricing: $149–$299/month by dose self-pay
- With insurance: May be as little as $25 with the savings offer if covered
- Coverage: Expected to follow similar PA requirements as injectable
What to Watch in 2026
- Employer plan renewals: Self-funded employers will decide whether to add/remove GLP-1 coverage during their annual renewals
- PBM formulary updates: Express Scripts, CVS Caremark, OptumRx typically announce formulary changes in late fall
- Oral Wegovy: New form may provide alternative access pathway
Note: All timelines, pricing, and coverage expansions are subject to final implementation. Verify with your specific plan.
What Should You Do Now?
- Verify your 2026 benefits: During open enrollment, confirm whether your employer plan will cover Wegovy next year
- Consider plan switching: If your current plan is dropping coverage, evaluate other options during open enrollment
- Medicare patients: Ask your prescriber about the Medicare GLP-1 Bridge ($50 per monthly fill, July 1, 2026 – December 31, 2027); Part D BALANCE Model: Delayed, with no new start date
- Need financial help? Wegovy savings programs and patient assistance can reduce costs to as little as $25 with commercial coverage (Wegovy is not on Novo Nordisk’s Patient Assistance Program list)
WEGOVY INSURANCE COVERAGE
Frequently Asked Questions
It depends on your plan. Large employer plans are most likely to cover Wegovy with prior authorization—about 43% of companies with 5,000+ employees cover it. Some BCBS, UHC, Aetna, and Cigna plans also cover it depending on your specific plan. Most marketplace plans exclude it for weight loss. By law, basic Medicare Part D coverage excludes it for weight loss, but Medicare enrollees may qualify through the Medicare GLP-1 Bridge (outside Part D), with conditions.
Your best bet is a large employer plan. About 43% of companies with 5,000+ employees cover GLP-1s for weight loss, compared to 30% of large employers (1,000-4,999) and 16% of mid-size employers (200-999). Marketplace plans rarely cover it; Medicare covers it for weight loss only through the Medicare GLP-1 Bridge, with conditions. Even with coverage, expect to need prior authorization.
Yes, with conditions, through the Medicare GLP-1 Bridge, a temporary CMS program that runs outside your Part D benefit. By law, basic Medicare Part D coverage excludes drugs used for weight loss, but the Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027) covers Wegovy for weight loss for $50 per monthly fill if you meet CMS’s eligibility criteria and your prescriber gets prior authorization. Wegovy may also be covered under Part D for cardiovascular risk reduction (adults with established cardiovascular disease and either obesity or overweight), subject to the plan’s formulary, prior authorization and exceptions process (another FDA indication). BALANCE Model (Part D): Delayed, with no new start date.
Medicaid coverage varies by state. State Medicaid programs covering GLP-1s for obesity: 13 states (as of January 2026); others exclude them or require special authorization. Always verify coverage directly with your state Medicaid program, as policies change frequently.
Yes, almost always. More than 88% of plans that cover Wegovy require prior authorization. Insurers typically request BMI documentation, evidence of weight-related medical conditions, lifestyle program participation, and sometimes prior treatment history before approving coverage.
Many insurers classify Wegovy as a weight-loss medication, which is excluded under many pharmacy benefit designs. These exclusions are based on employer benefit structures and PBM formulary policies—not the drug manufacturer or pharmacy.
Yes. If your employer self-funds its health plan (common at large companies), they have authority to add Wegovy coverage even if the insurer's standard plans exclude it. Your HR or benefits administrator can confirm whether your employer allows exceptions or has negotiated to include GLP-1 coverage.
The oral Wegovy (pill form) was FDA approved in December 2025 and reached pharmacies in January 2026. Coverage is expected to follow similar prior authorization requirements as injectable Wegovy. Some insurers may initially exclude it while updating formularies. Check with your insurer for the latest coverage policies.
Insurance Coverage for Other GLP-1s
Coverage varies significantly by medication. Compare your options:
References
- Kaiser Family Foundation. (October 2025). "2025 Employer Health Benefits Survey." Coverage rates by employer size: 16% of mid-size employers (200-999 workers), 30% of large employers (1,000-4,999), and 43% of very large employers (5,000+) cover GLP-1 medications for weight loss. https://www.kff.org/health-costs/2025-employer-health-benefits-survey/
- Kaiser Family Foundation. (2024). "Medicaid Coverage of and Spending on GLP-1s." Tracking of state Medicaid GLP-1 coverage policies: 13 states (as of January 2026) covered GLP-1s for obesity, with policies evolving. https://www.kff.org/medicaid/issue-brief/medicaid-coverage-of-and-spending-on-glp-1s/
- Kaiser Family Foundation. (January 2025). "Medicare Advantage Prior Authorization Determinations (2023)." 81% of MA appeals succeed; we use a conservative 65%+ estimate for commercial insurance. https://www.kff.org/medicare/nearly-50-million-prior-authorization-requests-were-sent-to-medicare-advantage-insurers-in-2023/
- American Medical Association. (2024). "Over 80% of prior auth appeals succeed." https://www.ama-assn.org/practice-management/prior-authorization/over-80-prior-auth-appeals-succeed-why-aren-t-there-more
Last updated October 6, 2026 · Key facts verified October 5, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.